AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32900266
Drug: Maintenance ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance ketamine therapy (1 mg/kg, once or twice weekly for 3 months)
Trial: 37943580
Drug: Supervised therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised therapy
Trial: 35522253
Drug: Physical Activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Activity Group (PAG) - two weekly group exercise sessions and two to three home-based exercise sessions per week
Trial: 33295128
Drug: Bilateral erector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral erector spinae plane block using 20 mL bupivacaine 0.25% at the level of the T7 transverse process
Trial: 33295128
Drug: Bilateral sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral sham block using 20 mL normal saline
Trial: 32410819
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination of 150 mg of econazole with 6 mg of benzydamine
Trial: 32410819
Drug: Econazole single-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Econazole single-drug formulation
Trial: 32410819
Drug: Benzydamine single-drug
RxNorm normalized name: benzydamine
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine single-drug formulation
Trial: 34293615
Drug: FFC group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FFC group: tap water containing FFC (0.15g/L) given daily for 5 days
Trial: 34293615
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: normal drinking water and feed given daily
Trial: 36186931
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Crocus sativus capsules twice daily
Trial: 34427941
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tapentadol
Trial: 33979487
Drug: Medical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical management (episodic antimicrobial treatment)
Trial: 32250190
Drug: Topical olopatadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical olopatadine hydrochloride 0.1%
Trial: 35109889
Drug: Kangxianhuanji granule,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kangxianhuanji granule, 10 g each time, two times daily for 4 weeks
Trial: 35109889
Drug: Placebo granule,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo granule, 10 g each time, two times daily for 4 weeks
Trial: 34552099
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus ATR inhibitor (berzosertib)
Trial: 35419986
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (rhTNFR:Fc PFS and LYO)
Trial: 33418457
Drug: SPN-812 (viloxazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPN-812 (viloxazine extended-release) 100-600 mg/day
Trial: 35094667
Drug: 6 mg·kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg·kg‐1 caffeine + 10% maltodextrin (CHO+CAFMR)
Trial: 35094667
Drug: 6 mg·kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg·kg‐1 caffeine (CAFMR)
Trial: 34938848
Drug: Take Care
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL SPRAY [Take Care Clinic Instant Hand Sanitizer Spray]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Take Care of Me program (8-week online integrated treatment with 12 modules)
Trial: 35830497
Drug: Fitbit in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fitbit in combination with behaviour change strategies (FB+)
Trial: 32135143
Drug: Expedited partner
RxNorm normalized name: Milkthistle Fruit (Silybum Marianum L. Gaertner)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expedited partner therapy awareness
Trial: 32135143
Drug: Expedited partner
RxNorm normalized name: Milkthistle Fruit (Silybum Marianum L. Gaertner)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expedited partner therapy prescription receipt
Trial: 32135143
Drug: Willingness to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Willingness to dispense expedited partner therapy prescriptions
Trial: 32135143
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of azithromycin for chlamydia treatment
Trial: 32135143
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of cefixime for gonorrhea treatment
Trial: 33644992
Drug: Repository corticotropin
RxNorm normalized name: Repository Corticotropin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repository corticotropin injection (RCI) 80 units twice weekly for 12 weeks, followed by either RCI or placebo for another 12 weeks.
Trial: 32493448
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin A supplementation
Trial: 32289741
Drug: Gliclazide 60
RxNorm normalized name: Gliclazide 60 mg prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide 60 mg
Trial: 33287271
Drug: L-band PALSAR-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-band PALSAR-2
Trial: 33060436
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3, 2000 IU/day for 6 months
Trial: 34083338
Drug: Relating Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relating Therapy (RT) plus Treatment as Usual (TAU)
Trial: 32981536
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg slow-release)
Trial: 35960649
Drug: Systemic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic administration of lidocaine (SA, lidocaine 1%)
Trial: 33487259
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 300,000 IU vitamin D3
Trial: 32064725
Drug: CIN-Zn (756.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIN-Zn (756.6 μmol/L cinnamaldehyde and 70 μmol/L zinc)
Trial: 32064725
Drug: CIT (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIT (1.6 mmol/L citral)
Trial: 32064725
Drug: CIT-ISO (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIT-ISO (1.6 mmol/L citral and 1.3 mmol/L isopulegol)
Trial: 33124098
Drug: Control (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (conventional treatment)
Trial: 35605426
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol (20 mg; 40 mg; 80 mg; 80 mg; and 80 mg)
Trial: 35605426
Drug: Intravenous hydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydralazine (10 mg, up to 5 doses)
Trial: 33709237
Drug: High suspension
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High suspension and low incision (HSLI) surgery
Trial: 39117415
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses
Trial: 36302125
Drug: ABI-H2158 (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H2158 (100, 300, or 500 mg QD or 300 mg BID)
Trial: 36302125
Drug: ABI-H2158 (5-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H2158 (5-500 mg single ascending dose)
Trial: 36302125
Drug: ABI-H2158 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H2158 (300 mg QD or BID for 10 days)
Trial: 36302125
Drug: ABI-H2158 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H2158 (300 mg QD for 14 days)
Trial: 37153876
Drug: Daratumumab monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab monotherapy
Trial: 35387759
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg Ursodeoxycholic acid (UDCA) for 6 months
Trial: 34224554
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran with reduced particle size (WB RPS), 20 g daily for 1 month
Trial: 34674667
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium bicarbonate tablets titrated up to a maximum of 3 g bd (6 g total) for 12 weeks
Trial: 34740020
Drug: HCV communication
RxNorm normalized name: HCV-086
DrugBank: HCV-086 (DB05884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV communication with alters currently enrolled in drug treatment
Trial: 34740020
Drug: HCV communication
RxNorm normalized name: HCV-086
DrugBank: HCV-086 (DB05884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV communication with alters sharing drug preparation equipment
Trial: 34740020
Drug: HCV communication
RxNorm normalized name: HCV-086
DrugBank: HCV-086 (DB05884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV communication with alters with daily/weekly interactions
Trial: 33256626
Drug: Trial Sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trial Sequential Analysis
Trial: 39023253
Drug: Abemaciclib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abemaciclib plus endocrine therapy
Trial: 38723189
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol
Trial: 38723189
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist protocol
Trial: 33639116
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (CPTG)
Trial: 36053841
Drug: Narcotic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narcotic medication
Trial: 32930952
Drug: Deferasirox (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferasirox (20 mg/kg)
Trial: 36575425
Drug: Exposure-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure-based therapy
Trial: 34556006
Drug: Emotion-focused group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emotion-focused group therapy (EFGT)
Trial: 32346962
Drug: Oral Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Tranexamic Acid (TXA) 250 mg twice daily
Trial: 32824394
Drug: Exercise treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise treatment group
Trial: 36215327
Drug: Digital home
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital home exercise program (12-week duration, four exercises daily)
Trial: 34297066
Drug: Placebo (lactated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactated Ringer's solution)
Trial: 32354590
Drug: Subcutaneous mepivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous mepivacaine
Trial: 32964203
Drug: Allopurinol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (300 mg/d)
Trial: 35373862
Drug: DHA fish
RxNorm normalized name: Fish Oil 1000 MG Oral Capsule, Liquid Filled [OMEGA-3 EPA & DHA FISH OIL CONCENTRATE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA fish oil supplement (1491 mg DHA + 351 mg eicosapentaenoic acid per day)
Trial: 32880050
Drug: Contrast water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast water therapy (CWT, alternately 10 °C and 38 °C)
Trial: 34751757
Drug: Early surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early surgical treatment
Trial: 33749041
Drug: DBB (Deproteinized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBB (Deproteinized Bovine Bone) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Trial: 33749041
Drug: DBB/BM (Deproteinized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBB/BM (Deproteinized bovine bone associated with fresh autologous bone marrow) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Trial: 35476631
Drug: 150 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 μg/kg ivermectin
Trial: 35450573
Drug: Metoprolol 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 150 mg
Trial: 33409591
Drug: Sequential romosozumab-to-alendronate
RxNorm normalized name: romosozumab
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sequential romosozumab-to-alendronate treatment
Trial: 32672427
Drug: Renal-replacement therapy
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal-replacement therapy initiation timing
Trial: 33188966
Drug: Various treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments for lateral ankle sprain
Trial: 33616875
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin (BI)
Trial: 35901105
Drug: Non-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment control group (regular physical activity)
Trial: 34275593
Drug: Losartan (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (25 to 100 mg/day, flexibly titrated by week 6)
Trial: 33891569
Drug: Neem capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neem capsules (50 mg of neem-leaf extract, twice a day for 28 days)
Trial: 33891569
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules (twice a day for 28 days)
Trial: 33891569
Drug: Neem capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neem capsules
Trial: 33891569
Drug: Neem capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neem capsules and Placebo
Trial: 35010916
Drug: Curcumin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (500 mg twice daily)
Trial: 32000093
Drug: Acceptance and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance and Commitment Therapy (ACT), 12 sessions
Trial: 35837991
Drug: empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: empagliflozin 10 mg
Trial: 35000470
Drug: Stellarex low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stellarex low-dose paclitaxel drug-coated balloon (DCB)
Trial: 32369162
Drug: Smoked cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoked cannabis administration (50.6 mg THC)
Trial: 32369162
Drug: Vaporized cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaporized cannabis administration (50.6 mg THC)
Trial: 32369162
Drug: Oral cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cannabis administration (50.6 mg THC)
Trial: 33736940
Drug: Postoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiotherapy (50‐54 Gy to the mediastinum using intensity‐modulated radiation therapy or proton beam therapy)
Trial: 33047127
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg nicotine/mL cherry
Trial: 33047127
Drug: 18 mg/mL
RxNorm normalized name: menthol 18 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 mg/mL cherry
Trial: 33047127
Drug: 6 mg/mL
RxNorm normalized name: phenol 6 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/mL chocolate
Trial: 33047127
Drug: 18 mg/mL
RxNorm normalized name: menthol 18 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 mg/mL chocolate
Trial: 33210434
Drug: 10 mg/mL
RxNorm normalized name: urea 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/mL triamcinolone acetonide (TA)
Trial: 33210434
Drug: 5 mg/mL
RxNorm normalized name: urea 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/mL triamcinolone acetonide (TA)
Trial: 33210434
Drug: 2.5 mg/mL
RxNorm normalized name: iodine 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/mL triamcinolone acetonide (TA)
Trial: 35791616
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea leaf extract (GTE) tablet
Trial: 35931636
Drug: SARS-CoV-2 vaccine
RxNorm normalized name: SARS-CoV-2 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SARS-CoV-2 vaccine group
Trial: 35390511
Drug: Amantadine 200
RxNorm normalized name: amantadine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 200 mg per day for 14 days
Trial: 32820003
Drug: Spiriva Respimat
RxNorm normalized name: Spiriva Respimat
DrugBank: Tiotropium (DB01409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiriva Respimat (2.5 μg twice a day) in combination with ICS/LABA
Trial: 32820003
Drug: Spiriva HandiHaler
RxNorm normalized name: Spiriva HandiHaler
DrugBank: Tiotropium (DB01409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiriva HandiHaler (18 μg once a day) in combination with ICS/LABA
Trial: 33913348
Drug: Food and
RxNorm normalized name: ThickenUp Clear Instant Food and Beverage Thickener Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food and Nutrition Education Program with Sensory and Cognitive Exercises (PESC), consisting of four weekly workshops.
Trial: 33913348
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no workshops), evaluated twice with a one-month interval.
Trial: 34994286
Drug: N-acetylcysteine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine plus low dose contraceptive
Trial: 34994286
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose contraceptive alone
Trial: 33201202
Drug: Care bundle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care bundle including early intravenous nitrate boluses, management of precipitating factors, and moderate dose of intravenous diuretics (median 27.0 mg of intravenous nitrates in the first 4 hours).
Trial: 36111429
Drug: Erenumab (ERE)
RxNorm normalized name: erenumab
DrugBank: Erenumab (DB14039)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Erenumab (ERE) 140 mg
Trial: 33249580
Drug: Galcanezumab (GMB)
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab (GMB) 240 mg
Trial: 32791965
Drug: Pre-anesthesia best
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-anesthesia best possible medication history (PA-BPMH) performed by a clinical pharmacist
Trial: 36286834
Drug: Selective VDRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective VDRA (zemplar 1 mcg/day)
Trial: 36286834
Drug: Non-selective VDRA
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-selective VDRA (alfacalcidol 0.25 mcg/day)
Trial: 32569068
Drug: Topical vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical vancomycin powder (1000 mg)
Trial: 36410628
Drug: Topical lidocaine-prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine-prilocaine
Trial: 34420949
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation with 2.3 g of omega-3 fatty acids (n-3 FAs)
Trial: 35899748
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2000 IU/day vitamin D and 1g/day omega-3 fatty acids for 5 years
Trial: 35897060
Drug: Trifluridine/tipiracil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifluridine/tipiracil plus panitumumab (6 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Trial: 35897060
Drug: Trifluridine/tipiracil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifluridine/tipiracil plus bevacizumab (5 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Trial: 33423966
Drug: Stereotactic radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stereotactic radiation therapy
Trial: 32992898
Drug: Probiotics (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (Lactobacillus acidophilus, L. casei, L. helveticus, Bifidobacterium bifidum) for 60 days (n = 8)
Trial: 32978696
Drug: Melatonin (MLT)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MLT) 40 mg/kg
Trial: 32978696
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (FA) 2 mg/kg
Trial: 35606865
Drug: Oral antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotic bowel preparation (OABP) with neomycin 1 g and metronidazole 0.9 g the day before surgery
Trial: 35606865
Drug: No special
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No special intestinal preparation (control group)